+39.3%
ASML vs SBAC
-0.4%
+39.7%
-31.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | SBAC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.0% | -1.9% | +6.9% | +4.7% |
| 7D | -9.0% | +1.2% | -10.2% | -8.7% |
| 30D | -21.0% | +11.2% | -32.1% | -19.4% |
| 3M | -16.3% | +4.5% | -20.7% | -15.4% |
| 6M | -7.5% | -12.2% | +4.6% | -7.6% |
| YTD | +34.0% | -0.1% | +34.1% | +37.6% |
| 1Y | +39.3% | -0.3% | +39.5% | +43.0% |
| All | +39.3% | -0.4% | +39.7% | +43.0% |
Cumulative growth
Daily Returns
Daily percentage return beside SBAC.
Daily Out/Under-Performance
Portfolio return minus SBAC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SBAC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded SBAC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling